US Bancorp’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7K | Sell |
5,470
-540
| -9% | -$1.94K | ﹤0.01% | 3167 |
|
|
2025
Q1 | $18K | Buy |
+6,010
| New | +$18K | ﹤0.01% | 3205 |
|
|
2024
Q2 | – | Sell |
-2,900
| Closed | -$11.7K | – | 3955 |
|
|
2024
Q1 | $11.7K | Buy |
+2,900
| New | +$11.7K | ﹤0.01% | 3274 |
|
|
2023
Q3 | – | Sell |
-1,015
| Closed | -$3.8K | – | 3961 |
|
|
2023
Q2 | $3.8K | Buy |
+1,015
| New | +$3.8K | ﹤0.01% | 3522 |
|
|
2023
Q1 | – | Sell |
-264
| Closed | -$1.27K | – | 4062 |
|
|
2022
Q4 | $1.27K | Sell |
264
-100
| -27% | -$481 | ﹤0.01% | 3860 |
|
|
2022
Q3 | $2K | Buy |
+364
| New | +$2K | ﹤0.01% | 3775 |
|
|
2022
Q2 | – | Sell |
-207
| Closed | -$1K | – | 4045 |
|
|
2022
Q1 | $1K | Sell |
207
-42
| -17% | -$203 | ﹤0.01% | 3881 |
|
|
2021
Q4 | $2K | Buy |
249
+202
| +430% | +$1.62K | ﹤0.01% | 3832 |
|
|
2021
Q3 | $2K | Buy |
47
+32
| +213% | +$1.36K | ﹤0.01% | 3816 |
|
|
2021
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 3961 |
|